| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jan 24 | ERNA Eterna Therapeutics | Stock Option Common Stock, par value $0.005 per share | Grant | Acquire A | No | No | 1.8 | 168,521 | 303.34 k | 168,521 |
| 7 Nov 23 | CMRA Comera Life Sciences | Stock Option (Right to Purchase Common Stock | Grant | Acquire A | No | No | 0.355 | 14,200 | 5.04 k | 14,200 |
